Bull Rankings model

Interparfums, Inc. (IPAR) stock analysis

Household & Personal Products. Scored on the same transparent model behind the daily rankings.

★
IPAR
Interparfums, Inc. · Household & Personal Products
50.5Score
$112.21Oct 9 close$3.6B
1Y Target$126.50Analyst consensus · 6 analysts
5Y Target$185.21Compound horizon
10Y Target$274.74Long-dated conviction
FCF$243mTTM · 06/26
C
FCF $243m — modest; watch for margin expansion · Trailing twelve months to 06/26 (operating cash flow − capex).
Rev+2.5%FY YoY
C
Revenue +2.5% — flat, mature phase or headwinds present · Computed from the last two annual revenue figures (FY YoY).
D/E0.15
A-
D/E 0.15 — less debt than most Consumer Defensive peers (≈25th pctile)
P/E21.4x
B
P/E 21.4 — near the Consumer Defensive median (≈60th pctile)
PEG*—
—
PEG n/a — analysts expect next year's earnings to be no higher than last year's

* PEG n/a — analysts expect next year's earnings to be no higher than last year's

Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology

Quality-growth score · 50.5
Quality87.8
Growth38.6
Value38.1
Why this score
  • Durable high returns
Entry · Margin of safety
52-week rangeNear 52-week high
13% off the 12-month high
vs DCF fair value17% aboveest. fair value ~$96
What the price assumes: free cash flow growing about 7% next year, slowing to 4% a year by year ten — vs a starting rate of ~2% our model takes as the middle of three readings — analyst estimates, last year's revenue growth, and the company's own multi-year record.

Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards

Why now
Household & Personal Products · market cap $3.6b. 13% off the 52-week high of $129.29. 6 sell-side analysts rate this a Hold with a mean 1-yr target of $126.50 (implying +13% upside).
Moat
ROE 19% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 145% of net income, helped by cash released from working capital ($27m, chiefly inventory sold down) that doesn't repeat every year.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
Horizon
1-3 yr $126.50 (6-analyst consensus) — fundamentals + valuation re-rating. 5 yr $185.21 at ~11% CAGR — compounding case rests on the competitive position widening. 10 yr $274.74 if current growth sustains into durable earnings power.

IPAR vs the Top Picks average

PillarIPARBook avgDiff
Quality8883+5
Growth3989-50
Value3876-38

Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.

Trend
-14.7 over 81 daily scores
From 65.2 (Jun 22) → 50.5 (now)

One point per daily run; read From → To for the actual range.

IPAR at a glance

THE BULL RANKINGS SCORECARD50.5/ 100 · BULL SCOREPEER MEDIANQUALITY87.8GROWTH38.6VALUE38.1Reverse-DCF · Price implies ~7% growth a year from here.
PRICE vs OUR DCF FAIR VALUE$93.7$97.3FAIR-VALUE RANGE$112PRICEOur DCF fair value ~$95.8 · price $112 is 17% above it.
ONE-YEAR MOVE VS ITS BETAFLATThis stock+21%Trailing one-year price change. Price history is not an inputto the Bull Rankings score.
PRICE IN ITS 52-WEEK RANGE$112LOW $77.2HIGH $129Trading at the 67th percentile of its 52-week range ($77.2–$129).

Same audited fundamentals as the score, unless a card says otherwise.

Analyst estimate revisions

30-day change+0.0%
90-day change-6.7%
Forward EPS estimate$5.20

Over the last 90 days, what analysts expect IPAR to earn is materially lower (-6.7%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →

Shares to buy
17
Position size
$1,908
3.8% of portfolio
Stop price
$84.16
25% below $112.21
$ at risk if stopped
$476.89
budget $500.00 · 1% of portfolio

Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.

Interparfums, Inc. (IPAR): score, valuation & FAQ

Interparfums, Inc. (IPAR) is a Household & Personal Products company that scores 50.5 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are D/E (A-). On valuation, IPAR sits about 17% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 7% next year, slowing to 4% a year by year ten.

Is IPAR a good stock to buy?

Bull Rankings scores IPAR 50.5 out of 100 on its quality-growth model, which is a middling reading. That is driven by D/E (A-). A score is a quantitative screen of Interparfums, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does IPAR score 50.5 on Bull Rankings?

The score leans on quality at 87.8 out of 100, with value the weakest pillar at 38.1 — the three combine geometrically, so a weak one cannot be papered over by a strong one. IPAR earns its highest marks on D/E (A-). Each signal is graded against sector-aware thresholds rather than one absolute bar, so IPAR is measured against Household & Personal Products peers, not against the market as a whole.

Is IPAR overvalued or undervalued?

Based on $112.21, IPAR sits about 17% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 7% next year, slowing to 4% a year by year ten. It trades at a 21.4x P/E (graded B). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in IPAR?

Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.

New to these metrics? See the guides and the methodology.

More Household & Personal Products stocks by score

All Consumer Defensive rankings →

Analyze another ticker →